Page-1
VICC BRE 12101 A Phase Ib Trial of BYL719 (an α-Specific PI3K... VICC RAD 1060 A Phase I Trial of Sorafenib and Stereotactic... VICC BRE 1114 Phase II Trial of AKT Inhibitor MK2206 in... VICC PHI 1065 A phase IA, multicenter, open-label dose... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... VICCBRE1202 A phase Ib, open-label, dose-escalation study of... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... Click here to print
this page (PDF) Metastatic HER2-